Argus
•
Oct 28, 2026
LMAT: What does Argus have to say about LMAT?
Summary
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Baxter International Inc.
Oct 29, 2026
•
BAX
Analyst Report: Boston Scientific Corporation
Oct 28, 2026
•
BSX
MMSI: Raising target price to $103.00
Oct 28, 2026
•
MMSI
ENSG: Lowering target price to $186.00
Oct 28, 2026
•
ENSG
ADUS: Raising target price to $133.00
Oct 28, 2026
•
ADUS
